The largest database of trusted experimental protocols
> Physiology > Physiologic Function > Vascular Resistance

Vascular Resistance

Vascular Resistance is a measure of the opposition to blood flow through the vascular system.
It is a critical factor in regulating blood pressure and organ perfusion.
This term encompasses the resistance encountered by blood flow through the arteries, capillaries, and veins, which is influenced by factors such as vessel diameter, blood viscosity, and the activity of the sympathetic nervous system.
Understanding vascular resistance is key in the study of cardiovascular physiology and the development of treatments for conditions like hypertension, atherosclerosis, and peripheral artery disease.
Researchers can leverage AI-driven platforms like PubCompare.ai to optimize their vascular resistance studies, locate the best research protocols, and enhance the reproducibility and accuarcy of their findings.

Most cited protocols related to «Vascular Resistance»

The parameters of the three-element Windkessel outflow models were calculated as described below. Given a target diastolic (Pd) and systolic (Ps) pressure, and flow rate at the inlet (Qin(t)), the initial estimate for the net peripheral resistance (RT) was calculated as [50 (link)]
RT=Pm-PoutQ¯in,Pm=Pd+13(Ps-Pd), where in is the mean flow rate and Pm is the mean blood pressure, assumed uniform throughout the arterial network. We then calculated the resistance R1 + R2 at the outlet of each terminal vessel that yields the desired flow distribution and satisfies
1RT=j=2M1R1j+R2j, where M is the number of terminal branches and j = 1 corresponds to the aortic root. For each individual outlet, the proximal resistance (R1) is assumed to be equal to the characteristic impedance of the upstream 1-D domain; i.e.
R1=ρfcdAd, where cd and Ad are, respectively, the wave speed and area at diastolic pressure (Pd). This choice of R1 minimizes the magnitude of the waves reflected at the outlet of the 1-D domain [38 ].
The total compliance (CT) was calculated from either (i) the time constant τ = 1.79 s of the exponential fall-off of pressure during diastole given in [51 ] or (ii) using an approximation to
CT=dVdP , where V(t) is the total blood volume contained in the systemic arteries. According to [50 (link)],
CT=τRT, which can be calculated once RT is determined using Eq. (13). Alternatively,
CT=dVdP can be approximated by [50 (link)]
CT=Qmax-QminPs-PdΔt, where Qmax and Qmin are the maximum and minimum flow rates at the inlet and Δt is the difference between the time at Qmax and the time at Qmin. We use both Eqs. ( 16) and (17) depending on the available input data.
According to [52 (link)] we have
CT=Cc+Cp,Cc=i=1NC0Di,Cp=j=2MR2jCjR2j+R1j, where Cc is the total arterial conduit compliance, Cp is the total arterial peripheral compliance, N is the total number of vessels in the 1-D domain, M < N is the number of terminal branches (j = 1 denotes the inlet and is not included in the sum), R1, R2, and C are parameters of the three-element Windkessel model (Fig. 1) and C0D is the compliance of each vessel, which is calculated as
C0D=AdLρf(cd)2, where L is the length of the vessel. We calculated Cp = CTCc and distributed it following the methodology described by Alastruey et al. [52 (link)] More specifically, we have
Cj=CpRTR2j+R1j, where j is the terminal compliance of each branch distributed in proportion to flow as described by Stergiopulos et al. [2 (link)]. We then introduced a correction factor to arrive at the final value of Cj:
Cj=CjR2j+R1jR2j=CpRTR2j.
This expression follows from a linear analysis of the 1-D equations in a given arterial network in which each terminal branch is coupled to a three-element Windkessel model [52 (link)].
For all of the simulations, the Windkessel compliances and resistances (Cj, j = 2, …, M), (
R1j and
R2j , j = 2, …, M) were iteratively calculated to achieve physiologically realistic pressure ranges. To reach a desired pulse pressure (Ppulse = PsPd) and diastolic pressure (Pd) at a particular vessel, we calculated
RT0 and
CT0 given by Eqs. (13) and (16) or (17) using the iterative formulae
RTn+1=RTn+ΔPmnQ¯in,ΔPmn=Pd-Pdn,
CTn+1=CTn-Qmax-Qmin(Ppulsen)2ΔtΔPpulsen,ΔPpulsen=Ppulse-Ppulsen, where the superscript n is the iteration number of the windkessel parameter estimation process performed using the 1-D formulation, and
Pdn and
Ppulsen are the diastolic and pulse pressure, respectively, at a specific target location in the 1-D model, typically the inlet, at each iteration. Equations (22) and (23) follow from a first-order Taylor expansion of Eqs. (13) and (17) around the current mean and pulse pressures
Pmn and
Ppulsen , respectively, with
ΔPmn approximated using the change in diastolic pressure. The total compliance was adjusted by altering the total peripheral compliance Cp, since the total conduit compliance Cc is a function of the vessel geometry and wall stiffness. This process was iterated using the 1-D model until
Pdn and
Ppulsen were smaller than 1% of the target Pd and Ppulse, respectively. Fig. 2 shows the evolution of the systolic, mean and diastolic pressure, net peripheral resistance and total compliance calculated using the 1-D formulation to match the target systolic and diastolic pressures for the baseline aorta model. The final values of the Windkessel compliances and resistances were used in the 3-D counterparts of the 1-D models.
Other methods have been proposed in the literature to estimate the parameters of the outflow boundary conditions. A root-finding method is described by Spilker and Taylor [53 (link)] in the context of 3-D models with compliant arterial walls. Devault et al. proposed a Kalman-filter based methodology in a 1-D model of the circle of Willis [54 (link)].
Publication 2013
A-A-1 antibiotic Aorta Aortic Root Arteries Biological Evolution Blood Vessel Blood Volume Circle of Willis Diastole PDN-1 Plant Roots Pressure Pressure, Diastolic Pulse Pressure Systole Total Peripheral Resistance Vascular Resistance
Reservoir pressure (figure 2) was calculated from the ensemble averaged radial tonometric waveforms recorded by the Sphygmocor device without the application of a generalized transfer function. In brief, sphygmocor *.txt files were saved and data subsequently imported into Matlab (Mathworks, Inc, Natick, Massachusetts, USA) for analysis using customised programs based on (10 (link);21 (link)). Further details are provided in Supplementary data. Reservoir pressure is assumed to vary temporally in the same way throughout aorta and large elastic arteries, but with a time lag that depends on the location and wave propagation characteristics of the arteries (13 (link)). Mass conservation in an arterial system containing N vessels requires
Q0(t)=nNCndP¯(tτn)dt+nNP¯(tτn)PRn
where Q0(t) is the volume flow rate at the aortic root, Cn is the compliance of the vessel segment n, P¯(t) is the reservoir pressure at the aortic root, P¯(tτn) is the reservoir pressure in vessel n, Rn is the resistance of vessel n, τn is the time it takes for a wave to travel from the aortic root to vessel n and P is the pressure at zero flow.
Excess pressure in vessel n (XSPn) is defined as the difference between the measured pressure Pn(t) and the reservoir pressure
XSPn(t)=Pn(t)P¯(tτn)
Hydraulic work done by the ventricle (W) depends on the volume flow rate Qot and the pressure in the aortic root
W=0τP¯(t)Q0(t)dt
where t corresponds to the cardiac period. This work can be separated into reservoir and excess work
W=0τP¯(t)Q0(t)dt+0τXSP0(t)Q0(t)dtW¯+XSW
where reservoir work (W¯) is the hydraulic work done by the ventricle against the reservoir pressure and the excess work (XSW) is the work done against the excess pressure at the aortic root. For a given flow, Qo(t) the integral of the excess pressure (XSPI) is therefore an index of the excess work done by the ventricle.
Publication 2014
Aorta Aortic Pressure Aortic Root Arteries Blood Vessel Heart Heart Ventricle Medical Devices Plant Roots Pressure Tonometry, Ocular Vascular Resistance
Pulsed-wave and color Doppler ultrasound examination of the uterine and umbilical arteries was performed in patients with preeclampsia (Acuson, Sequoia, Mountain View, CA) using a 3.5 or a 5 MHz curvilinear probe. Transducers were directed toward the iliac fossa, the external iliac artery was imaged in a longitudinal section, and the uterine artery was mapped with color Doppler as it crossed the external iliac artery. Pulsed-wave Doppler was performed of both uterine arteries and when three similar consecutive waveforms were obtained, the resistance index (RI) of the right and left uterine arteries was measured and the mean RI of the two vessels was calculated. Uterine artery Doppler velocimetry30 (link) was defined as abnormal if either the mean RI was above the 95th percentile for gestational age31 (link)or in the presence of a bilateral early diastolic notch.32 (link) The Doppler signal of the umbilical artery was obtained from a free floating loop of the umbilical cord during the absence of fetal breathing and body movement. When three similar consecutive waveforms were obtained, the pulsatility index (PI) was measured. Umbilical artery Doppler velocimetry was defined as abnormal if either the PI was above the 95th percentile for gestational age using the reference range proposed by Arduini and Rizzo33 (link)or in the presence of abnormal waveforms (absent or reversed end diastolic velocities) as described by Trudinger et al.34 (link) The patients were classified into the following 4 groups: 1) Normal Doppler velocimetry in the uterine and the umbilical arteries; 2) Doppler abnormalities in the uterine artery alone; 3) Doppler abnormalities in the umbilical artery alone; and 4) Doppler abnormalities in both vessels.
Publication 2010
Arteries Blood Vessel Congenital Abnormality Diastole Fetus Fossa, Iliac Gestational Age Iliac Artery Movement Patients Pre-Eclampsia Pregnancy Sequoia Transducers Ultrasonography, Doppler, Pulsed Ultrasounds, Doppler Umbilical Arteries Umbilical Artery, Single Umbilical Cord Uterine Anomalies Uterine Arteries Uterus Vascular Resistance Velocimetry
The CE-IVD labeled Rarecells® Device and its consumables (Rarecells Diagnostics, France) were used to assess the in vitro performance of the ISET® standard protocol for marker-independent isolation of fixed tumor cells from blood (Fig 1A). The Rarecells® Buffer solution (ref. 54 0203) was reconstituted according to the manufacturer instructions. The reconstituted buffer solution can be stored frozen at -20°C for up to 6 months. Before use, the pH is adjusted to 7.2. Formaldehyde is then added for cell fixing and to obtain a 0.74% final concentration. 90 mL of Rarecells® buffer is then used to dilute ten mL of blood (10-fold dilution) to prepare it for filtration. Blood pretreatment has to take place for exactly 10 minutes under constant gentle stirring on a horizontal mixer (CAT Ingenieurbüro model# RM5-40).
A disposable cartridge (Rarecells® Block) containing a filter having proprietary characteristics and 8 microns nominal pores size is set into the device. The cartridge contains 6 compartments: a large compartment for filtration of 5 mL of blood and 5 smaller compartments, each one for filtration of 1 mL of blood. The compartments are independent, allowing filtering variable volumes of blood from 10 μL to 10 mL of blood (100 μL to 100 mL of diluted blood). Empty compartments have to be closed during filtration with Rarecells® Block lids.
The protocol starts with filtration of 50 mL of sterile PBS to hydrate the filter, then the diluted blood is loaded (100 mL of 1:10 diluted blood) into the Rarecells® Block and filtered at a typical standard calibrated depression of -10 kPa. Blood filtration lasts no longer than a minute. Since the degree of blood cellularity may be variable due to physiological or pathological conditions and may increase blood resistance to filtration, the device allows increasing the depression for a few seconds if needed in order to complete filtration. This method allows maintaining a minimum shear force and sticks the cells to the filter avoiding their loss. The tubes that contained the diluted blood are then rinsed with 100 mL of sterile PBS that is also filtered in a few seconds. The cartridge is released from the device and disassembled in order to extract and gently rinse the ISET® filter with sterile distilled water. Fixed cells are left to dry and attach firmly to the filter at room temperature for 15 to 30 minutes.
The filter contains 10 circular areas (spots) and each spot contains the CRC that were, before filtration, in one mL of blood along with some residual leukocytes.
The technical characteristics of the Block allow processing 1 to 10 mL of blood by ISET®, while the number of spots still corresponds to the number of milliliters of blood filtered. The counting of the number of CTC per mL then conveniently corresponds to the number of spots counted.
Full text: Click here
Publication 2017
BLOOD Blood Cells Blood Volume Buffers Cells Cell Separation Diagnosis Exanthema Filtration Formaldehyde Freezing Leukocytes Medical Devices Neoplasm Metastasis Neoplasms Pathologic Processes physiology Sterility, Reproductive Technique, Dilution Vascular Resistance
Detailed information about the trial design has been published previously.25 (link),26 (link) The study protocol is available with the full text of this article at NEJM.org. Eligible participants were enrolled at seven clinical sites from February 2006 through June 2009. All the participants provided written informed consent. Participants were randomly assigned in a 1:1 ratio to lisinopril plus telmisartan or lisinopril plus placebo. Randomization was performed centrally with the use of permuted blocks. In addition, participants were randomly assigned in a 1:1 ratio to a standard blood-pressure target (120/70 to 130/80 mm Hg) or a low blood-pressure target (95/60 to 110/75 mm Hg), with stratification according to age, sex, race, baseline estimated GFR, and clinical site. The last study visit was in June 2014.
Participants underwent standardized imaging27 (link) in a 1.5-T MRI scanner to determine total kidney volume, left-ventricular-mass index, and renal blood flow at baseline and at 24, 48, and 60 months. Renal vascular resistance was calculated on the basis of blood flow and mean arterial pressure.28 Image analysis was performed,27 (link) and strict quality-control measures were maintained throughout the study.
After randomization, treatment with lisinopril and the masked study medication (telmisartan or placebo) was initiated, and the doses were adjusted in a stepwise fashion to achieve the desired blood-pressure targets (with the use of home blood-pressure measures) while the plasma levels of creatinine and potassium were monitored. Second-, third-, and fourth-line antihypertensive agents were added as needed (Table S1 in the Supplementary Appendix, available at NEJM .org). Central measurements of the serum creati-nine level and local measurements of blood urea nitrogen and electrolytes were obtained at all clinical-site visits, and 24-hour urine collections were obtained for central measurements of albumin, sodium, potassium, creatinine, and aldosterone excretion annually. Adherence to therapy was calculated as the number of drug cards (32 pills per card) given to patients minus the number returned unused during the study period, divided by the number of months of study participation.
Publication 2014
Albumins Aldosterone Antihypertensive Agents Blood Circulation Blood Pressure Contraceptives, Oral Creatinine Electrolytes Kidney Left Ventricles Lisinopril Patients Pharmaceutical Preparations Placebos Plasma Potassium Renal Circulation Serum Sodium Telmisartan Therapeutics Urea Nitrogen, Blood Urine Specimen Collection Vascular Resistance

Most recents protocols related to «Vascular Resistance»

Both devices configurations were individually and consecutively tested on the same testing loop (Figure 1). The conditions for the study were simulated by using a test loop specifically configured for biventricular testing (15 (link)), which has been used previously for characterization of other CF devices and disease states. The test loop has two pneumatic pumps (Abiomed AB5000, Danvers, MA, USA) powered from a dual-output driver (Figure 2). The working fluid in the test loop was a blood analog glycerin/water mixture with a specific gravity of 1.060. Manual valves simulated vascular resistances, closed pneumatic reservoirs created arterial compliances, and pump inlets were filled by open reservoirs. Inflows for both BVADs were connected to the loop in both ventricular and atrial positions. Adjustable parameters for the loop included: fluid volumes, drive pressures, beat rates for pumps, loop compliance, vascular resistance (systemic and pulmonary), and shunt flows between all four chambers. For this study, we varied the drive pressures to simulate four different conditions: moderate left heart failure (LHF), moderate right heart failure (RHF), moderate biventricular failure (BHF), and severe BHF (Table 1).
Full text: Click here
Publication 2023
A-A-1 antibiotic Arteries BLOOD Glycerin Heart Atrium Heart Failure Heart Ventricle Left-Sided Heart Failure Lung Medical Devices Vascular Resistance
The smoothed 2D meshes were imported into Star CCM+ (Siemens cd-adapco, 2020.3, version 15.06.007-R8,) to create polyhedral meshes, with a median mesh size of 509,269 (IQR: 126,501–1,927,197). Mesh independence of these kinds of simulations were previously investigated and assured (19 ).
The blood flow simulations were performed by solving the Navier-Stokes equations and were based on the finite volume method. Walls were assumed to be rigid. Simulation settings included laminar flow (Reynolds numbers in the aorta are in the order of 2,000) and the blood was modeled as a Newtonian fluid with a dynamic viscosity of 0.004 Pa*s and a constant density of 1,050 kg/m3. Blood is an inhomogeneous fluid, but the effect of non-Newtonian behaviour in large vessels is negligible. Therefore, modeling the blood as a Newtonian fluid a satisfactory assumption for the aorta. Due to the retrospective design of the study, direct flow or pressure measurements of inflow conditions were not available. Therefore, inflow was set at a constant cardiac output velocity of 0.4 m/s approximating the average normal flow velocity in the ascending aorta (8 (link)), outlet boundaries were defined as zero pressure outlets (i.e., no distally increased vascular resistance). Extensions were created at the ascending aorta and all vessel branches, to have a fully developed flow at the inlet and to avoid outlet boundary conditions effects on the outlets.
Publication 2023
Aorta Ascending Aorta BLOOD Blood Circulation Blood Vessel Cardiac Output Muscle Rigidity Pressure Vascular Resistance Viscosity
The detailed structural parameters of the Panax notoginseng xylem were shown in the scanning electron microscopy images. The flow resistance characteristics of the vessel were analyzed by the computational fluid dynamics method [11 (link), 18 (link)]. Based on the microscopic images of the cross-section and axial-section, the structural parameters of the annular thickening and pitted thickening vessel were measured. The measurements were taken for each character listed in Table 1.
The types of vessel cross-sections were shown in Fig 2. The terms of the annular thickening and pitted thickening vessel were shown in Fig 3, which R was inscribed circle diameter, W was width, S was spacing, H was height, L was length.
The actual structural parameters of the xylem were obtained from the Panax notoginseng samples (Table 1), and the computational domain model of the annular thickening and pitted thickening vessel was established based in SolidWorks. The hexagon vessels of Panax notoginseng were shown in Fig 4.
The computational domain models contained a flow area with a secondary wall thickening pattern of 250 μm in length. To avoid effects at the entrance and exit, an extended smooth segment with length 25 μm was added at both ends of the vessel (Fig 5).
The boundary conditions were that the pressure was zero at the model outlet, and the flow velocity was 0.3 mm/s at the model inlet. The irregularity of the vessel structure was generated by tetrahedral and hexahedral unstructured meshes. The maximum and minimum of the unit size were 4.4×10-6m and 4.4×10-8m, respectively. In this part, the scale of the mesh was based on the prediction accuracy of the inlet/outlet pressure drop, and the mesh size independence test was performed (Table 2). The pressure drop difference between the standard mesh and the fine mesh was 0.22%. The mesh number has no effect on the calculation results, so the standard mesh number was used to analyze flow resistance characteristics, and the total number of meshes in the model was approximately 728680 (Fig 6). The PowerCube-S01 with a high-performance computing system was used for the simulation.
Full text: Click here
Publication 2023
Blood Vessel Character Hydrodynamics Microscopy Panax notoginseng Pressure Scanning Electron Microscopy Vascular Resistance Xylem
The hexagonal xylem vessel model (Fig 7) can analyze the flow characteristics by the energy conservation law (Bernoulli equation). The flow between arbitrary sections satisfies the Bernoulli equation, which was written in sections from the inlet to the exit sections Z1, Z2, ···, Zn as:
P1ρg+V122g+z1=P2ρg+V222g+z2+ξ1V222g+λl1V228DgP2ρg+V222g+z1=P3ρg+V322g+z3+ξ2v322g+λl2V328DgPn1ρg+Vn122g+zn1=Pnρg+Vn22g+zn+ξn1Vn22g+λln1Vn28Dg
Where Pn and Vn were the average pressure and flow velocity at section n, ρ was fluid density, g was the acceleration of gravity, Zn was the position head of water at the section, ξn−1 was the local loss coefficient of section n-1 to section n, λ was friction factor of head loss, ln−1 was the length between two adjacent sections. D was the hydraulic radius of the xylem vessel, the expression of D was:
D=Aχ
Add the two sides of the equations of Eq (1) in order:
P1Pnρg=znz1+ξ1V222g+ξ2V322g++ξn1Vn22g+λLVn28Dg
Where l1+l2+l3+···+ln-1= L, L was the total length of the xylem vessel.
Known by the continuity equation:
V1A1=V2A2=V3A3==VnAn
In Eq (4), Ai(i = 1,2…,n) was the flow area at the corresponding section, Substituting Eq (4) into Eq (3) give:
ΔPρg=L+[λ(A1An)2L4D+i=1n1ξi(A1Ai+1)2]V122g
Where
ξ=[λ(A1An)2L4D+i=1n1(A1Ai+1)2ξi]
Eq (6) was simplified to:
ΔPρg=L+ξV122g
Expressed as:
ξ=2V12(ΔPρLg)
Expressed by flow rate:
ξ=24R4q2(ΔPρLg)
In Eqs (8A, 8B), was the flow resistance coefficient of hexagonal xylem vessel, q was the average flow rate.
For pentagon, quadrilateral and circular xylem vessel model, the expressions were:
ξ=50R4(tan36)2q2(ΔPρLg)
ξ=32R4q2(ΔPρLg)
ξ=2π2R4q2(ΔPρLg)
Full text: Click here
Publication 2023
Acceleration Blood Vessel Friction Gravity Head Pressure Radius Vascular Resistance Xylem
We performed an ultrasound study using duplex ultrasonography and B-mode to examine the graft using Toshiba Aplio 500 machines at our hospital. Two senior neuroradiologists reviewed and recorded the ultrasonography images independently; neither of them were involved in the surgery and they were blinded to the clinical information. The patient was placed in a supine position to maintain the incident angle of 60° or less between the STA and the Doppler beam. Probing the artery trunk of the STA in front of the tragus, we gradually traced along the trunk to the distal end until the STA entered the skull. Branch vessels were confirmed to be operated upon, and the junction of the intracranial-extracranial segment was selected as the check point. If a double barrel was involved, the check point was changed to a location 3–5 mm proximal to the bifurcation of the frontal and parietal branches of the STA.
The blood flow (ml/min), diameter (mm), pulsatility index (PI), and resistance index (RI) values were calculated automatically by the software and recorded when the measurement was usable. The recorded diameter is the maximum internal diameter of a blood vessel during cardiac contraction. The recorded flow is the average blood flow over a complete cardiac cycle. The RI value reflects the elasticity of the vascular wall and the resistance at the distal end of the blood flow. It equals to (Vs-Vd)/Vs, (Vs: peak systolic flow velocity, Vd: end diastolic flow velocity). Pi value reflects the activity, hardness and the resistance of blood vessel during the whole cardiac cycle. It equals to (Vs-Vd)/Vm (Vm: Space Peak time average velocity, the average value of flow velocity at each point during the whole cardiac cycle).
Ultrasound examination was conducted for patients pre-operatively, and follow-ups were scheduled at 1 day, 7 days, 3 months, and 6 months after surgery. Ultrasonographic data were recorded only according to the examination results, and data acquisition was blinded to the angiographic results.
Full text: Click here
Publication 2023
Angiography Arteries Blood Circulation Blood Vessel Cranium Diastole Elasticity Grafts Heart Myocardial Contraction Operative Surgical Procedures Patients Systole Ultrasonography Ultrasonography, Doppler, Duplex Vascular Resistance

Top products related to «Vascular Resistance»

Sourced in Australia, United States, United Kingdom, New Zealand, Germany, Japan, Spain, Italy, China
PowerLab is a data acquisition system designed for recording and analyzing physiological signals. It provides a platform for connecting various sensors and transducers to a computer, allowing researchers and clinicians to capture and analyze biological data.
Sourced in United States, Japan, United Kingdom, Austria, Canada, Germany, Poland, Belgium, Lao People's Democratic Republic, China, Switzerland, Sweden, Finland, Spain, France
GraphPad Prism 7 is a data analysis and graphing software. It provides tools for data organization, curve fitting, statistical analysis, and visualization. Prism 7 supports a variety of data types and file formats, enabling users to create high-quality scientific graphs and publications.
Sourced in United States
The Piccolo Xpress Chemistry Analyzer is a compact, point-of-care instrument designed for rapid and accurate analysis of a range of clinical chemistry parameters. It utilizes a single-use reagent disc to perform multiple tests from a small sample volume, providing fast and reliable results.
Sourced in United States
The Discovery RX is a laboratory equipment product offered by GE Healthcare. It is designed to perform basic analytical tasks in a clinical laboratory setting. The core function of the Discovery RX is to enable reliable and efficient data collection and analysis for researchers and healthcare professionals.
Sourced in United States
The STE LightSpeed 64 is a computed tomography (CT) scanner developed by GE Healthcare. It is designed to perform high-speed, high-resolution imaging of the body's internal structures. The system utilizes a 64-slice detector configuration to capture multiple slices of data simultaneously, enabling rapid image acquisition and reconstruction.
Sourced in Canada, United States, Japan
The Vevo 2100 is a high-resolution, real-time in vivo imaging system designed for preclinical research. It utilizes advanced ultrasound technology to capture detailed images and data of small animal subjects.
Sourced in United States, United Kingdom
The IU22 ultrasound scanner is a medical imaging device manufactured by Philips. The core function of the IU22 is to capture and display real-time images of the body's internal structures, such as organs, tissues, and blood flow, using high-frequency sound waves.
Sourced in Finland, United States, Japan
The 1470 Wizard is a gamma counter designed for the measurement of radioactive samples. It provides accurate and reliable results for a variety of radioassay applications. The core function of the 1470 Wizard is to detect and quantify gamma radiation emitted from samples placed within the instrument.
Sourced in United States, Canada, United Kingdom, Germany
The MP150 is a data acquisition system designed for recording physiological signals. It offers high-resolution data capture and features multiple input channels to accommodate a variety of sensor types. The MP150 is capable of acquiring and analyzing data from various biological and physical measurements.

More about "Vascular Resistance"

Vascular resistance (VR) is a critical factor in regulating blood pressure and organ perfusion.
It is a measure of the opposition to blood flow through the cardiovascular system, encompassing the resistance encountered in the arteries, capillaries, and veins.
Factors such as vessel diameter, blood viscosity, and sympathetic nervous system activity can influence vascular resistance.
Understanding VR is essential for the study of cardiovascular physiology and the development of treatments for conditions like hypertension, atherosclerosis, and peripheral artery disease.
Researchers can leverage AI-driven platforms like PubCompare.ai to optimize their vascular resistance studies.
This platform helps locate the best research protocols from literature, preprints, and patents, enabling enhanced reproducibility and accuracy in studies.
Researchers can also utilize PowerLab, GraphPad Prism 7, Piccolo Xpress Chemistry Analyzer, Discovery RX, STE LightSpeed 64, Vevo 2100, IU22 ultrasound scanner, and 1470 Wizard to measure and analyze vascular resistance data.
By simplifying the research process and unlocking new insights, PubCompare.ai can be a valuable tool for vascular resistance studies.
Undestanding vascular resistance is key to advancing cardiovascular physiology and developing effective treatments for related conditions.